Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Viridian Therapeutics Inc logo

Viridian Therapeutics Inc

Sector: Health Care and Social Assistance   

Industry: Medical Laboratories

18.71
 
USD
  
-1.46
  
(-7.24%)
Optionable: Yes  Market Cap: 1,031 M  90-day average vol: 952,900

Previous close: 20.17  Open: 20.86  Bid: 18.71  Ask: 19.72
52 week range    
10.93   
   33.32
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 1st March 2024
47
MarketXLS Rank
60
Value
46
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

VRDN Income Statement

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock49000.05000.0
AccruedPreferredStockDividends111 M79 M
Basic EPS from continuing operations-31.13
Basic EPS total-31.13-6.66-4.05
Basic weighted shares outstanding2 M539460.0614017.019 M30 M2 M4 M12 M32 M
Cost of sales-3 M-2 M-3 M
Depreciation-300000.0-300000.0-300000.0-300000.0-200000.0-100000.0-300000.0
Depreciation unreconciled-300000.0-300000.0-300000.0-300000.0-200000.0-100000.0
DepreciationAndAmortization-300000.0-300000.0-300000.0-300000.0-200000.0-100000.0-300000.0
Diluted EPS total-3.5-21.02-28.21-1.38-1.1-20.04-31.13-6.66-4.05
Diluted normalized net income/share-20.04-31.13
Diluted weighted shares outstanding2 M545623.0612336.019 M30 M2 M4 M12 M32 M
GainOnSaleOfPPE-100000.0
GainOnSaleOfSecurity3000.04000.0
GeneralAndAdministrativeExpense7 M8 M7 M11 M11 M12 M13 M26 M35 M
Gross operating profit954000.066000.03 M4 M
ImpairmentOfCapitalAssets797000.0
Income before tax-8 M-11 M-17 M-27 M-33 M-42 M-111 M-79 M-130 M
Income restructuring and M&A2 M-2 M-300000.0
Income taxes277000.0193000.0
Interest income39000.0403000.01 M941000.0173000.0318000.05 M
InterestExpenseNonOperating1 M141000.095000.0-500000.0
MiscOtherSpecialCharges3000.04 M8 M4 M1 M3 M2 M
Net income from total operations-8 M-11 M-17 M-27 M-33 M-42 M-111 M-79 M-130 M
NetIncomeCommonStockholders-8 M-11 M-17 M-27 M-33 M-42 M-221 M-79 M-130 M
NetIncomeContinuousOperations-8 M-11 M-17 M-27 M-33 M-42 M-111 M-79 M-130 M
NetNonOperatingInterestIncomeExpense-1 M-141000.0-287000.020000.0381000.0106000.0-335000.0315000.04 M
NonRecurringOperationExpense-100000.0
Operating income-7 M-11 M-17 M-31 M-41 M-46 M-111 M-83 M-136 M
Operating income before depreciation (EBITDA)-7 M-11 M-17 M-26 M-33 M-42 M-110 M-78 M-130 M
OperatingExpense-11 M11 M-20 M-31 M-41 M46 M111 M-83 M-136 M
Other income net-3000.0-4 M-8 M-4 M-1 M-3 M-2 M
OtherGandA7 M8 M7 M11 M11 M12 M13 M26 M35 M
OtherOperatingExpenses-177000.0141000.0166000.0-300000.0-300000.0
OtherunderPreferredStockDividend49000.05000.0111 M79 M
PreferredStockDividends49000.05000.0111 M79 M
RentAndLandingFees7 M8 M7 M11 M11 M12 M13 M26 M35 M
Research & development expense347000.01 M14 M20 M30 M35 M98 M57 M101 M
ResearchExpense347000.01 M14 M20 M30 M35 M98 M57 M101 M
RestructringAndMnAIncome2 M-2 M-300000.0
Revenue per share-300000.0-500000.0-500000.0
SalariesAndWages-4 M-3 M-198000.0-2 M-4 M-4 M-4 M-14 M-20 M
Selling Gen & administrative expense8 M10 M7 M11 M11 M12 M13 M26 M35 M
SellingAndMarketingExpense717000.03 M2 M
SellingExpense717000.03 M2 M
Special income/charges100000.0-3 M2 M300000.0
Total Income available for interest expense (EBIT)-7 M-11 M-17 M-27 M-33 M-42 M-111 M-79 M-130 M
Total common shares outstanding8 M11 M21 M30 M31 M53 M7 M26 M43 M
Total net income-8 M-11 M-17 M-27 M-33 M-42 M-111 M-79 M-130 M
Total ordinary shares53 M53 M53 M53 M53 M53 M53 M53 M53 M
Total revenues4 M3 M3 M4 M8 M3 M2 M
TotalExpenses-15 M9 M20 M-31 M-41 M46 M111 M-83 M-136 M
TotalRevenue4 M3 M3 M4 M8 M3 M2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University